Loading Events

All Events

  • This event has passed.

LC-Fatty Acid Oxidation Disorders: Recent Updates on the REN001 Study

Print Friendly, PDF & Email

August 18, 2022 @ 7:00 pm 8:00 pm

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.

Please join us for an update on the Reneo LC-FAOD study. Dr. Alex Dorenbaum, Chief Medical Officer at Reneo Pharmaceuticals will provide background about this clinical study and will answer your questions.